JonesTrading analyst Soumit Roy maintained a Buy rating on Anavex Life Sciences (AVXL - Research Report) today and set a price target of $40.00. The company's shares closed today at $10.33.Roy covers the Healthcare sector, focusing on stocks such as Curis, Mirati Therapeutics, and Anavex Life Sciences. According to TipRanks, Roy has an average return of 3.5% and a 32.41% success rate on recommended stocks. The word on The Street in general, suggests a Strong Buy analyst consensus rating for Anavex Life Sciences with a $39.25 average price target, representing a 279.96% upside. In a report released on September 26, H.C.
https://www.tipranks.com/news/blurbs/jonestrading-keeps-their-buy-rating-on-anavex-life-sciences-avxl?utm_source=advfn.com&utm_medium=referral
Anavex Life Sciences (NASDAQ:AVXL)
Historical Stock Chart
From Nov 2022 to Dec 2022 Click Here for more Anavex Life Sciences Charts.
Anavex Life Sciences (NASDAQ:AVXL)
Historical Stock Chart
From Dec 2021 to Dec 2022 Click Here for more Anavex Life Sciences Charts.